SA
PRME icon

Sanctuary Advisors’s Prime Medicine PRME Stock Holding History

Sanctuary Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.4K Sell
13,400
-494
-4% -$1.64K ﹤0.01% 2771
2026
Q1 		$48.4K Sell
13,894
-765
-5% -$2.91K ﹤0.01% 2492
2025
Q4 		$50.9K Buy
14,659
+336
+2% +$1.5K ﹤0.01% 2384
2025
Q3 		$79.3K Buy
+14,323
New +$58.2K ﹤0.01% 2362
2025
Q2 		– Sell
-23,822
Closed -$47.4K – 2431
2025
Q1 		$47.4K Buy
+23,822
New +$60.8K ﹤0.01% 2145

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sanctuary Advisors's PRME Position: Q2 2026 in Review

Sanctuary Advisors reduced its Prime Medicine (PRME) stake by 3.6% in Q2 2026, selling an estimated $1.64K and leaving 13,400 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Sanctuary Advisors first reported a position in PRME in Q1 2025 and has held it in 5 quarters since. The position peaked at $79.3K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Sanctuary Advisors held 13,400 shares of Prime Medicine worth $49.4K as of Q2 2026.
  • Sanctuary Advisors sold 494 Prime Medicine shares in Q2 2026, an estimated $1.64K.
  • Prime Medicine made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2771 holding.
  • Sanctuary Advisors first reported a position in Prime Medicine in Q1 2025 and has held it in 5 quarters since.
  • Sanctuary Advisors's Prime Medicine position peaked at $79.3K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.